Aeris
Natural health product licensed in Canada
- Licence holder
- Alcrea Health
- NPN or DIN-HM
- 80031046
- Status
- Inactive licence
- Licence date
- 29 March 2012
- Revision date
- Not provided
- Form
- Liquide
- Route of administration
- Orale
- Application type
- Non traditionnelle
If this product were sold in France
- Conditions légales
Glycyrrhiza glabra L.: La portion journalière recommandée ne doit pas conduire à une ingestion d'acide glycyrrhizinique supérieure à 100 mg. L'étiquetage doit comporter un avertissement avec la teneur suivante: "Ne pas utiliser pendant plus de 6 semaines sans avis médical." L'étiquetage doit comporter un avertissement déconseillant l'emploi chez les enfants.
arrêté du 24 juin 2014, annexe I. French orders of 9 May 2006 (nutrients), 24 June 2014 (plants) and 26 September 2016 (other substances), consolidated LEGI collection, retrieved 23 October 2026.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source | Maximum per day, adult |
|---|---|---|
| Glycyrrhiza glabra Source : Racine Extraction ratio : 10:1 Dry plant equivalent : 1,500 mg | 150 mg | Not calculated |
| Glycyrrhiza glabra Source : Stolons Extraction ratio : 10:1 Dry plant equivalent : 1,500 mg | 150 mg | Not calculated |
| Verbascum thapsus Source : Feuille | 200 mg | Not calculated |
| Pulmonaria officinalis Source : Feuille | 500 mg | Not calculated |
| Eucalyptus globulus Source : Feuille | 600 mg | Not calculated |
| Boswellia serrata Source : Gomme Potency : 65 % acid boswelique | 10 mg | Not calculated |
Non-medicinal ingredients
Sorbate de potassium, Eau purifiée, Feuille de stevia rebaudiana, Saveurs naturelles, Acide DL-malique, citrate de sodium
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes | Not specified | maximum: 1 Cuillère à thé | maximum: 1 day |
Uses authorised in Canada
La réglisse traditionnellement en phytothérapie comme expectorant pour aider à soulager les affections respiratoires telles que les catarrhes, la toux et la bronchite.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
- Contre-indications
Ne pas utiliser si vous prenez des diurétiques thiazidiques, des glucosides cardiotoniques, des corticostéroïdes, des laxatifs stimulants ou tout autre médicament pouvant aggraver les déséquilibres électrolytiques. Ne pas utiliser si vous souffrez d'hypokaliémie, d'hypertension artérielle, ou de troubles cardiovasculaires ou rénaux..
Source
Official Health Canada record, licence 80031046
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
The evidence date of this ingredient list is unknown.
Has the product changed? Photograph the packaging.